|
1
|
Veglia F and Gabrilovich DI: Dendritic
cells in cancer: The role revisited. Curr Opin Immunol. 45:43–51.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chang WJ, Du Y, Zhao X, Ma LY and Cao GW:
Inflammation-related factors predicting prognosis of gastric
cancer. World J Gastroenterol. 20:4586–4596. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kashimura S, Saze Z, Terashima M, Soeta N,
Ohtani S, Osuka F, Kogure M and Gotoh M: CD83(+) dendritic cells
and Foxp3(+) regulatory T cells in primary lesions and regional
lymph nodes are inversely correlated with prognosis of gastric
cancer. Gastric Cancer. 15:144–153. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu DP, Shi WW, Zhang TT, Lv HY, Li JB, Lin
A and Yan WH: Elevation of HLA-G-expressing DC-10 cells in patients
with gastric cancer. Hum Immunol. 77:800–804. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tsukayama S, Omura K, Yoshida K, Tanaka Y
and Watanabe G: Prognostic value of CD83-positive mature dendritic
cells and their relation to vascular endothelial growth factor in
advanced human gastric cancer. Oncol Rep. 14:369–375.
2005.PubMed/NCBI
|
|
6
|
Ishigami S, Natsugoe S, Tokuda K, Nakajo
A, Xiangming C, Iwashige H, Aridome K, Hokita S and Aikou T:
Clinical impact of intratumoral natural killer cell and dendritic
cell infiltration in gastric cancer. Cancer Lett. 159:103–108.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Niccolai E, Taddei A, Prisco D and Amedei
A: Gastric cancer and the epoch of immunotherapy approaches. World
J Gastroenterol. 21:5778–5793. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Coutant F and Miossec P: Altered dendritic
cell functions in autoimmune diseases: Distinct and overlapping
profiles. Nat Rev Rheumatol. 12:703–715. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Swiecki M and Colonna M: The multifaceted
biology of plasmacytoid dendritic cells. Nat Rev Immunol.
15:471–485. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lombardi VC, Khaiboullina SF and Rizvanov
AA: Plasmacytoid dendritic cells, a role in neoplastic prevention
and progression. Eur J Clin Invest. 45 Suppl 1:S1–S8. 2015.
View Article : Google Scholar
|
|
11
|
Kini Bailur J, Gueckel B and Pawelec G:
Prognostic impact of high levels of circulating plasmacytoid
dendritic cells in breast cancer. J Transl Med. 14:1512016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sciarra A, Lichtner M, Autran GA,
Mastroianni C, Rossi R, Mengoni F, Cristini C, Gentilucci A, Vullo
V and Di Silverio F: Characterization of circulating blood
dendritic cell subsets DC123+ (lymphoid) and
DC11C+ (myeloid) in prostate adenocarcinoma patients.
Prostate. 67:1–7. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang XM, Liu XS, Lin XK, Yu H, Sun JY,
Liu XK, Chen C, Jin HL, Zhang GE, Shi XX, et al: Role of
plasmacytoid dendritic cells and inducible costimulator-positive
regulatory T cells in the immunosuppression microenvironment of
gastric cancer. Cancer Sci. 105:150–158. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Demoulin S, Herfs M, Delvenne P and Hubert
P: Tumor microenvironment converts plasmacytoid dendritic cells
into immunosuppressive/tolerogenic cells: Insight into the
molecular mechanisms. J Leukoc Biol. 93:343–352. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tamura T, Ohira M, Tanaka H, Muguruma K,
Toyokawa T, Kubo N, Sakurai K, Amano R, Kimura K, Shibutani M, et
al: Programmed death-1 Ligand-1 (PDL1) expression is associated
with the prognosis of patients with stage II/III gastric cancer.
Anticancer Res. 35:5369–5376. 2015.PubMed/NCBI
|
|
16
|
Kalb ML, Glaser A, Stary G, Koszik F and
Stingl G: TRAIL(+) human plasmacytoid dendritic cells kill tumor
cells in vitro: Mechanisms of imiquimod- and IFN-α-mediated
antitumor reactivity. J Immunol. 188:1583–1591. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tel J, Smits EL, Anguille S, Joshi RN,
Figdor CG and de Vries IJ: Human plasmacytoid dendritic cells are
equipped with antigen-presenting and tumoricidal capacities. Blood.
120:3936–3944. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gerlini G, Urso C, Mariotti G, Di Gennaro
P, Palli D, Brandani P, Salvadori A, Pimpinelli N, Reali UM and
Borgognoni L: Plasmacytoid dendritic cells represent a major
dendritic cell subset in sentinel lymph nodes of melanoma patients
and accumulate in metastatic nodes. Clin Immunol. 125:184–193.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sawant A, Hensel JA, Chanda D, Harris BA,
Siegal GP, Maheshwari A and Ponnazhagan S: Depletion of
plasmacytoid dendritic cells inhibits tumor growth and prevents
bone metastasis of breast cancer cells. J Immunol. 189:4258–4265.
2012. View Article : Google Scholar : PubMed/NCBI
|
